Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma

por Iwamoto, Fabio M., Hormigo, Adília
Publicado 2014

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy

por Desland, Fiona A., Hormigo, Adília
Publicado 2020

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting

por Vieira de Castro, Joana, Gonçalves, Céline S., Hormigo, Adília, Costa, Bruno M.
Publicado 2020

Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement

por Connelly, Jennifer, Hormigo, Adília, Mohilie, Nimish, Hu, Jethro, Chaudhry, Aafia, Blondin, Nicholas
Publicado 2016

MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting

por Sakai, Yu, Yang, Chen, Kihira, Shingo, Tsankova, Nadejda, Khan, Fahad, Hormigo, Adilia, Lai, Albert, Cloughesy, Timothy, Nael, Kambiz
Publicado 2020

Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report

por Umphlett, Melissa, Shea, Stephanie, Tome-Garcia, Jessica, Zhang, Yizhou, Hormigo, Adilia, Fowkes, Mary, Tsankova, Nadejda M., Yong, Raymund L.
Publicado 2020

Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study

por Restrepo, Paula, Yong, Raymund, Laface, Ilaria, Tsankova, Nadejda, Nael, Kambiz, Akturk, Guray, Sebra, Robert, Gnjatic, Sacha, Hormigo, Adilia, Losic, Bojan
Publicado 2020

Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma

por Ding, Bi-Sen, James, Daylon, Iyer, Rajiv, Falciatori, Ilaria, Hambardzumyan, Dolores, Wang, Su, Butler, Jason M., Rabbany, Sina Y., Hormigo, Adília
Publicado 2013

Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion

por Kihira, Shingo, Tsankova, Nadejda M, Bauer, Adam, Sakai, Yu, Mahmoudi, Keon, Zubizarreta, Nicole, Houldsworth, Jane, Khan, Fahad, Salamon, Noriko, Hormigo, Adilia, Nael, Kambiz
Publicado 2021

U-Net Based Segmentation and Characterization of Gliomas

por Kihira, Shingo, Mei, Xueyan, Mahmoudi, Keon, Liu, Zelong, Dogra, Siddhant, Belani, Puneet, Tsankova, Nadejda, Hormigo, Adilia, Fayad, Zahi A., Doshi, Amish, Nael, Kambiz
Publicado 2022

The future of cancer immunotherapy for brain tumors: a collaborative workshop

por Brown, Christine E., Bucktrout, Samantha, Butterfield, Lisa H., Futer, Olga, Galanis, Evanthia, Hormigo, Adilia, Lim, Michael, Okada, Hideho, Prins, Robert, Marr, Sara Siebel, Tanner, Kirk
Publicado 2022

Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign

por Kihira, Shingo, Derakhshani, Ahrya, Leung, Michael, Mahmoudi, Keon, Bauer, Adam, Zhang, Haoyue, Polson, Jennifer, Arnold, Corey, Tsankova, Nadejda M., Hormigo, Adilia, Salehi, Banafsheh, Pham, Nancy, Ellingson, Benjamin M., Cloughesy, Timothy F., Nael, Kambiz
Publicado 2023

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

por Galanis, Evanthia, Anderson, S Keith, Twohy, Erin, Butowski, Nicholas A, Hormigo, Adilia, Schiff, David, Omuro, Antonio, Jaeckle, Kurt A, Kumar, Shaji, Kaufmann, Timothy J, Geyer, Susan, Kumthekar, Priya U, Campian, Jian, Giannini, Caterina, Buckner, Jan C, Wen, Patrick Y
Publicado 2022

A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma

por Chiu, Daniel, Qi, Jingjing, Thin, Tin Htwe, Garcia-Barros, Monica, Lee, Brian, Hahn, Mary, Mandeli, John, Belani, Puneet, Nael, Kambiz, Rashidipour, Omid, Ghatan, Saadi, Hadjipanayis, Constantinos G., Yong, Raymund L., Germano, Isabelle M., Brody, Rachel, Tsankova, Nadejda M., Gnjatic, Sacha, Kim-Schulze, Seunghee, Hormigo, Adília
Publicado 2023